-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the National Medical Insurance Bureau exposed 10 typical cases of illegal violations by designated retail pharmacies, including the sale of non-medical insurance drugs or other commodities for medical insurance drugs, forged prescriptions or non-prescription drugs, sales of drugs that exceed medical insurance payment limits, and use of medical insuran.
Screenshot of the QR code of the electronic certificate, remote swiping card to purchase and sell medicines, settlement of medical insurance fees for non-designated retail pharmacies, and changing the venue of medical insurance settlement equipme.
At present, the violations of the above-mentioned designated retail pharmacies have been dealt with seriously in accordance with laws and regulatio.
Regarding the above situation, the industry believes that this once again reminds the management and staff of the majority of designated retail pharmacies to strictly abide by the medical insurance laws, regulations, rules, relevant policies and the medical insurance service agreement of the designated retail pharmacies to better protect the majority of the insuran.
personnel rights and interests, and jointly safeguard the safety of medical insurance fun.
It is understood that in order to protect the lives and health of the people, China has been continuously issuing documents to accelerate the standardization and professional development of retail pharmaci.
For example, in November last year, the State Food and Drug Administration released the newly revised "Measures for the Supervision and Administration of Drug Distribution and Use Quality (Draft for Comment.
The new "Draft for Comments" is very different from the previous versions of the draft for commen.
One is that the specifications are more detailed, the other is that the requirements are stricter, and the other is that the penalties for violations are heavi.
Taking the illegal sales of prescription drugs as an example, in the past, drug retail enterprises that failed to sell prescription drugs with prescriptions were given warnings and ordered to make corrections within a time lim.
Now, the "Draft of Opinions" requires that those who fail to sell prescription drugs by prescription shall be ordered to make corrections within a time limit and given a warning; those who fail to make corrections within the time limit shall be fined not less than 10,000 yuan but not more than 30,000 yu.
It should be noted that for those who do not make changes within the time limit, the fine is increased by 10 tim.
It can be clearly seen from the above that the state is further regulating the drug operation behavior of pharmacies, and the supervision of pharmacies is continuously tighteni.
In fact, under the influence of factors such as the accelerating trend of "prescription outflow", the pharmacy as the undertaker is destined to be highly regulat.
At present, various places are constantly issuing documents to strengthen the supervision of pharmacies, and the forms are becoming more and more diver.
For example, the regulatory department of Baiyin City, Gansu Province has previously implemented the "Internet + Smart Supervision" of compound preparations containing ephedrine in retail pharmacies in the ci.
It is understood that through this platform, regulatory authorities control the operation of retail pharmacies such as ephedrine-containing compound preparations, such as allocating exclusive QR codes to each pharma.
When customers purchase and scan the code, they can collect ephedrine-containing compound preparatio.
Purchasing information to achieve sales restrictions and over-awareness warnings for such dru.
In general, the supervision of pharmacies in the country and even around the world is becoming more and more stri.
The industry expects that in the future, driven by a series of regulations and supervision, pharmacies will continue to be standardized, informatized, and professionalized to accelerate development, and further Improve the market concentration of the pharmacy indust.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
Screenshot of the QR code of the electronic certificate, remote swiping card to purchase and sell medicines, settlement of medical insurance fees for non-designated retail pharmacies, and changing the venue of medical insurance settlement equipme.
At present, the violations of the above-mentioned designated retail pharmacies have been dealt with seriously in accordance with laws and regulatio.
Regarding the above situation, the industry believes that this once again reminds the management and staff of the majority of designated retail pharmacies to strictly abide by the medical insurance laws, regulations, rules, relevant policies and the medical insurance service agreement of the designated retail pharmacies to better protect the majority of the insuran.
personnel rights and interests, and jointly safeguard the safety of medical insurance fun.
It is understood that in order to protect the lives and health of the people, China has been continuously issuing documents to accelerate the standardization and professional development of retail pharmaci.
For example, in November last year, the State Food and Drug Administration released the newly revised "Measures for the Supervision and Administration of Drug Distribution and Use Quality (Draft for Comment.
The new "Draft for Comments" is very different from the previous versions of the draft for commen.
One is that the specifications are more detailed, the other is that the requirements are stricter, and the other is that the penalties for violations are heavi.
Taking the illegal sales of prescription drugs as an example, in the past, drug retail enterprises that failed to sell prescription drugs with prescriptions were given warnings and ordered to make corrections within a time lim.
Now, the "Draft of Opinions" requires that those who fail to sell prescription drugs by prescription shall be ordered to make corrections within a time limit and given a warning; those who fail to make corrections within the time limit shall be fined not less than 10,000 yuan but not more than 30,000 yu.
It should be noted that for those who do not make changes within the time limit, the fine is increased by 10 tim.
It can be clearly seen from the above that the state is further regulating the drug operation behavior of pharmacies, and the supervision of pharmacies is continuously tighteni.
In fact, under the influence of factors such as the accelerating trend of "prescription outflow", the pharmacy as the undertaker is destined to be highly regulat.
At present, various places are constantly issuing documents to strengthen the supervision of pharmacies, and the forms are becoming more and more diver.
For example, the regulatory department of Baiyin City, Gansu Province has previously implemented the "Internet + Smart Supervision" of compound preparations containing ephedrine in retail pharmacies in the ci.
It is understood that through this platform, regulatory authorities control the operation of retail pharmacies such as ephedrine-containing compound preparations, such as allocating exclusive QR codes to each pharma.
When customers purchase and scan the code, they can collect ephedrine-containing compound preparatio.
Purchasing information to achieve sales restrictions and over-awareness warnings for such dru.
In general, the supervision of pharmacies in the country and even around the world is becoming more and more stri.
The industry expects that in the future, driven by a series of regulations and supervision, pharmacies will continue to be standardized, informatized, and professionalized to accelerate development, and further Improve the market concentration of the pharmacy indust.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
